Overview

Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

Status:
Completed
Trial end date:
2017-07-26
Target enrollment:
Participant gender:
Summary
Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Davis
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Contraceptive Agents
Desogestrel
Etonogestrel